These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32327087)

  • 1. Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment: The EARLY Randomized Trial.
    Lemesle G; Laine M; Pankert M; Boueri Z; Motreff P; Paganelli F; Baumstarck K; Roch A; Kerbaul F; Puymirat E; Bonello L
    JACC Cardiovasc Interv; 2020 Apr; 13(8):907-917. PubMed ID: 32327087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis.
    Bonello L; Laine M; Puymirat E; Lemesle G; Thuny F; Paganelli F; Michelet P; Roch A; Kerbaul F; Boyer L
    JACC Cardiovasc Interv; 2016 Nov; 9(22):2267-2276. PubMed ID: 27884352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y
    Lemesle G; Laine M; Pankert M; Puymirat E; Cuisset T; Boueri Z; Maillard L; Armero S; Cayla G; Bali L; Motreff P; Peyre JP; Paganelli F; Kerbaul F; Roch A; Michelet P; Baumstarck K; Bonello L
    Clin Cardiol; 2018 Jan; 41(1):5-12. PubMed ID: 29356001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.
    Barbarawi M; Kheiri B; Zayed Y; Barbarawi O; Chahine A; Haykal T; Kanugula AK; Bachuwa G; Alkotob ML; Bhatt DL
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):185-193. PubMed ID: 31111670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of early and delayed invasive strategies in short-medium term among patients with non-ST segment elevation acute coronary syndrome: A systematic review and meta-analysis.
    Zhang MB; Guo C; Li M; Lv YH; Fan YD; Wang ZL
    PLoS One; 2019; 14(8):e0220847. PubMed ID: 31404097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial.
    Fagel ND; Amoroso G; Vink MA; Slagboom T; van der Schaaf RJ; Herrman JP; Patterson MS; Oosterwerff EFJ; Vos NS; Verheugt FWA; Tijssen JGP; de Winter RJ; Riezebos RK
    Am Heart J; 2021 Apr; 234():42-50. PubMed ID: 33422517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.
    Porto I; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimský P; Le Gall N; Zagar AJ; LeNarz LA; Miller D; Montalescot G;
    JACC Cardiovasc Interv; 2016 May; 9(9):897-907. PubMed ID: 27151605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
    Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
    Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention in the very elderly with NSTE-ACS: the randomized 80+ study.
    Hirlekar G; Libungan B; Karlsson T; Bäck M; Herlitz J; Albertsson P
    Scand Cardiovasc J; 2020 Oct; 54(5):315-321. PubMed ID: 32586153
    [No Abstract]   [Full Text] [Related]  

  • 10. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China).
    Yang Q; Wang Y; Liu J; Liu J; Hao Y; Smith SC; Huo Y; Fonarow GC; Ma C; Ge J; Taubert KA; Morgan L; Guo Y; Wang W; Zhou Y; Zhao D;
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28606999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate Versus Delayed Invasive Intervention for Non-STEMI Patients: The RIDDLE-NSTEMI Study.
    Milosevic A; Vasiljevic-Pokrajcic Z; Milasinovic D; Marinkovic J; Vukcevic V; Stefanovic B; Asanin M; Dikic M; Stankovic S; Stankovic G
    JACC Cardiovasc Interv; 2016 Mar; 9(6):541-9. PubMed ID: 26777321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial.
    Abtan J; Wiviott SD; Sorbets E; Popovic B; Elbez Y; Mehta SR; Sabatine MS; Bode C; Pollack CV; Cohen M; Moccetti T; Laanmets P; Faxon D; Okreglicki A; Ducrocq G; Steg PG;
    Arch Cardiovasc Dis; 2021 Mar; 114(3):187-196. PubMed ID: 33518473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Outcomes and Intervention Among Patients With Non-ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non-Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial).
    Badings EA; Hermanides RS; The SHK; Dambrink JE; Rasoul S; Van Wijngaarden J; Van 't Riet E; Kolkman E; Remkes WS; Tjeerdsma G; Van Der Wielen MLJ; Lok DJA; Suryapranata H; Van 't Hof AWJ
    Am J Cardiol; 2018 May; 121(10):1123-1128. PubMed ID: 29606324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.
    Stepinska J; Wojtkowska I; Annemans L; Danchin N; Pocock SJ; de Werf FV; Medina J; Bueno H
    Curr Vasc Pharmacol; 2020; 18(1):92-99. PubMed ID: 30588886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Murai T; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Hamaya R; Kanno Y; Lee T; Kakuta T
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1063-1074. PubMed ID: 29446567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial.
    Badings EA; The SH; Dambrink JH; van Wijngaarden J; Tjeerdsma G; Rasoul S; Timmer JR; van der Wielen ML; Lok DJ; van 't Hof AW
    EuroIntervention; 2013 May; 9(1):54-61. PubMed ID: 23685295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of management strategies in patients with prior coronary artery bypass grafting presenting with an acute coronary syndrome.
    Gouda P; Islam S; Dover DC; Kaul P; Bainey KR; Welsh RC
    Atherosclerosis; 2024 Jun; 393():117477. PubMed ID: 38643672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials.
    Jobs A; Mehta SR; Montalescot G; Vicaut E; Van't Hof AWJ; Badings EA; Neumann FJ; Kastrati A; Sciahbasi A; Reuter PG; Lapostolle F; Milosevic A; Stankovic G; Milasinovic D; Vonthein R; Desch S; Thiele H
    Lancet; 2017 Aug; 390(10096):737-746. PubMed ID: 28778541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.